Wegener's granulomatosis: ischemic stroke as the first clinical manifestation (case study).
Bares
Martin
M
Muchová
Miroslava
M
Dufek
Michal
M
Litzman
Jirí
J
Krupa
Petr
P
Rektor
Ivan
I
D019268:Antibodies, Antineutrophil Cytoplasmic / Q000097:blood / Q000276:immunology; D002545:Brain Ischemia / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D020526:Brain Stem Infarctions / Q000209:etiology* / Q000473:pathology / Q000503:physiopathology; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D014890:Granulomatosis with Polyangiitis / Q000150:complications* / Q000473:pathology / Q000503:physiopathology; D006801:Humans; D008279:Magnetic Resonance Imaging; D008526:Medulla Oblongata / Q000473:pathology* / Q000503:physiopathology; D008875:Middle Aged; D009413:Nerve Fibers, Myelinated / Q000473:pathology; D013687:Telencephalon / Q000473:pathology / Q000503:physiopathology; D016896:Treatment Outcome
D019268:Antibodies, Antineutrophil Cytoplasmic; D005938:Glucocorticoids; D003520:Cyclophosphamide